RECORDINGS & SLIDES AVAILABLE: 2026 ADAI Symposium on Cannabinoid Hyperemesis Syndrome
10/05/2026
The Dose Makes the Poison: Cannabinoid Hyperemesis Syndrome Goes Mainstream was hosted by ADAI on September 18, 2026. A full set of video recordings and slides are now available!
Cannabinoid Hyperemesis Syndrome (CHS) is becoming increasingly visible in clinical settings, but many providers are navigating diagnosis, treatment, and patient communication without clear guidance.
In a recent survey of Washington State healthcare providers, 70% reported treating patients experiencing severe abdominal pain, persistent nausea, retching, and relentless vomiting associated with heavy cannabis use.
Patients may not recognize cannabis as the cause of their symptoms, or may be skeptical that CHS exists at all, making effective care even more challenging.
Check out the recordings and slides from our day-long symposium to learn more about:
- What we know about CHS in Washington State and the U.S.—prevalence in hospitals, emergency departments, and community settings
- Recognition, diagnosis, treatment, and management across healthcare settings
- Communicating with patients about a contested diagnosis
- Policy strategies to reduce CHS and clinical strategies to increase CHS awareness and acceptance
